The prospective multi-centre BIO-LivIQ trial will enrol 325 patients across 60 sites worldwide.

International BIO-LivIQ Study Will Generate Evidence for Global LivIQ Leadless Pacemaker Approvals; Far-Field Sensing and ...

The placement device for the LivIQ leadless pacemaker. [Image courtesy of Biotronik] Biotronik today announced the initiation ...

Please provide your email address to receive an email when new articles are posted on . Left and right bundle branch blocks are associated with increased rates of pacemaker implantation after ...

Among Medicare beneficiaries, implantation was especially frequent for female patients and those undergoing tricuspid valve replacement with or without concomitant left-sided heart surgeries.

Around one in every nine patients who undergo TAVI with a new-generation self-expanding device will need permanent pacemaker implantation (PPI) within the next 30 days, according to an analysis of ...

Background Transcatheter aortic valve replacement (TAVR) has already been recommended for some high-risk patients with aortic ...

Needing a permanent pacemaker after surgical aortic valve replacement (SAVR) was linked to mortality in Swedish registry data. Such risk was not apparent in the first few years: all-cause mortality ...

Please provide your email address to receive an email when new articles are posted on . Among patients who had transcatheter aortic valve replacement, there was no difference in survival or adverse CV ...

Clinical pacemakers save lives. Implanted in patients’ hearts to keep them beating regularly, the devices are an important part of modern healthcare in the fight against potentially fatal arrhythmias.

Background: Patients over the age of 75 represent more than half the recipients of permanent pacemakers. It is not known if they have a different risk of complications than younger patients. Methods: ...